Zhejiang Huahai Pharmaceutical マネジメント
マネジメント 基準チェック /14
現在、CEO に関する十分な情報がありません。
主要情報
Bao Hua Chen
最高経営責任者
CN¥2.2m
報酬総額
CEO給与比率 | n/a |
CEO在任期間 | no data |
CEOの所有権 | 25.5% |
経営陣の平均在職期間 | データなし |
取締役会の平均在任期間 | データなし |
経営陣の近況
Recent updates
Investors Holding Back On Zhejiang Huahai Pharmaceutical Co., Ltd. (SHSE:600521)
Oct 22Here's Why Zhejiang Huahai Pharmaceutical (SHSE:600521) Has A Meaningful Debt Burden
Sep 25Zhejiang Huahai Pharmaceutical Co., Ltd.'s (SHSE:600521) Intrinsic Value Is Potentially 89% Above Its Share Price
Jun 20Zhejiang Huahai Pharmaceutical (SHSE:600521) Takes On Some Risk With Its Use Of Debt
May 28There May Be Some Bright Spots In Zhejiang Huahai Pharmaceutical's (SHSE:600521) Earnings
May 06Investors Don't See Light At End Of Zhejiang Huahai Pharmaceutical Co., Ltd.'s (SHSE:600521) Tunnel
Mar 22CEO(最高経営責任者
Bao Hua Chen (62 yo)
no data
在職期間
CN¥2,180,000
報酬
Mr. Bao Hua Chen serves as the President of TCM BU at Shanghai Pharmaceutical (Group) Co., Ltd. Mr. Chen serves as General Manager and Director at Zhejiang Huahai Pharmaceutical Co., Ltd and serves as its...